Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Glucose Health, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2011
FY2011
FY2012
FY2013
FY2014
FY2015
FY2016
Revenue
0
0
0
0
0.31
Cost of revenue
0
0
0
0
0.29
Gross profit
-0
-0
-0.02
0
0.02
Research and development
0
0
General and administrative
0.04
0.01
0.01
0.04
0.02
0.11
0.05
Operating expenses
0.61
0.89
0.36
1.27
0.52
0.16
0.11
Operating income
-0.61
-0.89
-0.36
-1.27
-0.55
-0.16
-0.09
Interest expense
0.02
0.01
0.04
0.17
0.11
0.12
0.32
Other non-operating income
-0.02
-0.01
-0.04
-0.19
-0.12
-0.11
-0.32
Pre-tax income
-0.4
-1.46
-0.67
-0.27
-0.41
Net income
-0.63
-0.9
-0.4
-1.46
-0.67
-0.27
-0.41
EPS, basic
-14.73
-9.82
-2.46
-4.91
-0.99
-0.14
-0.15
EPS, diluted
-14.73
-9.82
-2.46
-4.91
-0.99
-0.14
-0.15
Shares, basic (weighted)
0.04
0.07
0.15
0.3
0.68
1.96
2.79
Shares, diluted (weighted)
0.04
0.07
0.15
0.3
0.68
1.96
2.79
Balance sheet
FY2011
FY2011
FY2012
FY2013
FY2014
FY2015
FY2016
Cash and equivalents
0
0
0
0
0
0
0.02
Receivables
0
0.01
Inventory
0.09
0.02
0
0.01
Other current assets
0.03
0
0.04
0
0
Total current assets
0.09
0.03
0
0.03
0.04
0.02
0.03
Total assets
0.09
0.23
0.21
0.03
0.04
0.02
0.03
Accounts payable
0.38
0.3
0.12
0.14
0.15
0.09
0.14
Accrued liabilities
0.01
0.04
Short-term debt
0.05
0.08
0.17
Total current liabilities
0.68
0.42
0.19
0.22
0.32
0.4
0.53
Total liabilities
0.68
0.42
0.19
0.22
0.32
0.4
0.53
Paid-in capital
1.6
2.86
3.68
4.76
5.23
5.39
0.12
Retained earnings
-2.14
-2.87
-2.87
-4.9
-5.57
-5.84
-6.25
Other comprehensive income
-0.07
-0.07
-0.08
-0.08
-0.08
-0.08
-0.08
Shareholders' equity
-0.59
-0.19
0.02
-0.2
-0.28
-0.39
-0.5
Total equity
-0.59
-0.19
0.02
-0.2
-0.28
-0.39
-0.5
Total liabilities and equity
0.09
0.23
0.21
0.03
0.04
0.02
0.03
Shares outstanding
0.04
0.13
0.21
0.38
1.31
2.45
3.31
Cash flow statement
FY2011
FY2011
FY2012
FY2013
FY2014
FY2015
FY2016
Net income
-0.63
-0.9
-0.41
-1.46
-0.67
-0.27
-0.41
Stock-based compensation
0.03
0
Change in receivables
0
-0
-0.01
Change in inventory
-0
-0.02
0.01
0.01
-0.01
Change in payables
0.1
0.09
0.02
0.03
0.02
0.06
-0.13
Cash from operations
-0.11
-0.02
-0.08
-0.13
-0.14
-0.12
-0.04
Cash from investing
-0
0
Stock issued
0.01
Cash from financing
0.12
0.02
0.08
0.13
0.14
0.11
0.06
Exchange rate effect
-0.01
0
0.01
Net change in cash
0
0
0
-0
0
-0
0.02
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2017; growth uses fiscal years. Valuation uses the share price of $0.31 on September 28, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
65.4%
Gross profit / revenue.
Operating margin
-36.8%
Operating income / revenue.
Pre-tax margin
-96.5%
Pre-tax income / revenue.
Net margin
-106.6%
Net income / revenue.
Operating cash flow margin
-19.6%
Cash from operations / revenue.
Return on assets (ROA)
-356.6%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
7,232.0%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
1,018.0%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit growth, 1y
4,728.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
115.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
9.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-32.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
42.8%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
111.0%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
106.8%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.06x
Current assets / current liabilities.
Quick ratio
0.06x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.04x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.02
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.02
Revenue / diluted weighted shares.
Operating cash flow per share
-$0.00
Cash from operations / diluted weighted shares.
Book value per share
-$0.09
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
16.0x
Market cap / revenue.
EV/Sales
15.8x
Enterprise value / revenue.
Earnings yield
-6.7%
Net income / market cap (the inverse of P/E).
What was Glucose Health, Inc.'s revenue in fiscal 2016?
Glucose Health, Inc. reported revenue of $313.2K for fiscal 2016, 7,232.1% higher than the year before.
Was Glucose Health, Inc. profitable in fiscal 2016?
No. It reported a net loss of $410.4K.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.